This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimon, I. Articles by Harel, G. Search for Related Content PubMed PubMed Citation Articles by Shimon, I. Articles by Harel, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL MENOTROPINS

Ovarian Hyperstimulation without Elevated Serum Estradiol Associated with Pure Follicle-Stimulating Hormone-Secreting Pituitary Adenoma

Institutes of Endocrinology (I.S., T.R.) and Pathology (D.N.), and Department of Neurosurgery (M.H.), Sheba Medical Center, Tel-Hashomer 52621; Fertility Unit (I.B.-H.) and Endocrinology Service (G.H.), Rabin Medical Center, Golda Campus, Petah Tikva 49372; and Department of Molecular Cell Biology (A.A.), The Weizmann Institute of Science, Rehovot 76100, Israel

Abstract

We report a unique case of a 28-yr-old woman with a gonadotroph adenoma secreting FSH, presented with ovarian hyperstimulation, without elevation of serum estradiol. She presented with abdominal pain and large ovaries (both 10 cm in diameter) with multiple follicular cysts shortly after discontinuing oral contraceptive pills. She had a supranormal PRL level of 71 µg/liter (normal, <20), FSH of 8.4–9.2 IU/liter (normal for follicular phase, 2.4–10), LH of 0.01 IU/liter (normal, 1.6–9.3), estradiol of 108 pmol/liter (normal for follicular phase, 80–790), and free -subunit level of 0.11 µg/liter (normal, <1.8). A nuclear magnetic resonance study revealed invasive pituitary macroadenoma, 30 mm in diameter. Dopamine agonist (cabergoline) treatment normalized serum PRL but had no affect on FSH levels. A transsphenoidal surgery was performed, and most of the adenoma was resected. One month after surgery the patient resumed menstruation, and the hormonal profile included serum FSH of 6.3 IU/liter, LH of 2.1 IU/liter, estradiol of 156 pmol/liter, and PRL of 10 µg/liter. The excised adenoma tissue exhibited intense immunostaining for FSH and secreted this hormone to culture medium. Stimulation with TRH (both in vivo preoperatively and in vitro study of the excised tumor) had no effect on FSH secretion from the adenoma. Estradiol did not suppress FSH release from cultured adenoma cells. Patient serum samples showed significant FSH bioactivity when tested in a human granulosa cell line.

This case is remarkable because the ovarian hyperstimulation related to the FSH-secreting adenoma was not associated with high levels of serum estradiol, probably due to insufficient LH production by the normal pituitary. Thus, it supports the two-cell, two-gonadotropin theory, that both FSH and LH are necessary for normal ovarian estrogen production.

This article has been cited by other articles:

				T. Kajitani, S. Liu, T. Maruyama, H. Uchida, R. Sakurai, H. Masuda, T. Nagashima, M. Ono, T. Arase, and Y. Yoshimura Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report Hum. Reprod., February 1, 2008; 23(2): 435 - 439. [Abstract] [Full Text] [PDF]

				M. Ghayuri and J. H. Liu Ovarian Hyperstimulation Syndrome Caused by Pituitary Gonadotroph Adenoma Secreting Follicle-Stimulating Hormone Obstet. Gynecol., February 1, 2007; 109(2): 547 - 549. [Abstract] [Full Text] [PDF]

				T. Maruyama, H. Masuda, H. Uchida, T. Nagashima, and Y. Yoshimura Follicle Stimulating Hormone-Secreting Pituitary Microadenoma With Fluctuating Levels of Ovarian Hyperstimulation Obstet. Gynecol., May 1, 2005; 105(5): 1215 - 1218. [Abstract] [Full Text] [PDF]

				H. P. Mohammad, R. A. Abbud, A. F. Parlow, J. S. Lewin, and J. H. Nilson Targeted Overexpression of Luteinizing Hormone Causes Ovary-Dependent Functional Adenomas Restricted to Cells of the Pit-1 Lineage Endocrinology, October 1, 2003; 144(10): 4626 - 4636. [Abstract] [Full Text] [PDF]

				Y. Murata, H. Ando, T. Nagasaka, I. Takahashi, K. Saito, H. Fukugaki, K. Matsuzawa, and S. Mizutani Successful Pregnancy after Bromocriptine Therapy in an Anovulatory Woman Complicated with Ovarian Hyperstimulation Caused by Follicle-Stimulating Hormone-Producing Plurihormonal Pituitary Microadenoma J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1988 - 1993. [Abstract] [Full Text] [PDF]